Norpace CR

Norpace CR treats abnormal heart rhythms (arrhythmias). Can cause dry mouth, urinary retention, and blurred vision.

Norpace CR Overview

Reviewed: April 16, 2015
Updated: 

Norpace CR is a prescription medication used to treat life-threatening abnormal heart rhythms (arrhythmias). This medication belongs to a group of drugs called antiarrhythmics. It works by affecting sodium channels in the heart which slows electrical signals, stabilizing heart rhythm.

Norpace CR comes in an extended release capsule and is taken twice daily. Do not cut, crush, or chew extended-release capsules. Swallow them whole.

Common side effects include dry mouth, difficult urination, blurred vision, and dizziness. Do not drive or operate heavy machinery until you know how Norpace CR affects you.

 

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other
  • Arrhythmias, Cardiac
  • Atrial Fibrillation
  • Atrial Flutter
  • Atrial Premature Complexes
  • Tachycardia, Ventricular
  • Ventricular Premature Complexes

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Norpace CR Cautionary Labels

precautionsprecautions

Uses of Norpace CR

Norpace CR is a prescription medications used to treat life-threatening ventricular (lower chambers of the heart) arrhythmias.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Manufacturer

Norpace CR Drug Class

Norpace CR is part of the drug class:

Side Effects of Norpace CR

Serious side effects have been reported with Norpace CR. See the “Norpace CR Precautions” section.

Common side effects include:

  • dry mouth
  • difficult urination
  • constipation
  • blurred vision
  • dry eyes, nose, and throat
  • urinary retention
  • frequent urination
  • nausea
  • bloating and gas pains
  • dizziness
  • fatigue
  • muscle weakness
  • headache

This is not a complete list of Norpace CR side effects. Ask your doctor or pharmacist for more information.

Tell your doctor if you have any side effect that bothers you or that does not go away.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Norpace CR Interactions

Tell your doctor about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take:

  • medications that block a protein in the body (CYP3A4) such as some macrolide antibiotics (clarithromycin, telithromycin), some HIV protease inhibitors (indinavir, nelfinavir, ritonavir, saquinavir), some HCV protease inhibitors (boceprevir, telaprevir), some azole antifungals (ketoconazole, itraconazole, posaconazole, voriconazole), conivaptan (Vaprisol), delavirdine (Rescriptor), and nefazodone
  • verapamil
  • phenytoin

This is not a complete list of Norpace CR drug interactions. Ask your doctor or pharmacist for more information.

Norpace CR Precautions

Serious side effects have been reported with Norpace CR including the following: 

  • Heart Failure/Hypotension. Norpace CR may cause or worsen congestive heart failure or produce severe low blood pressure. Norpace should not be given to patients uncompensated or marginally compensated congestive heart failure or hypotension unless the congestive heart failure or hypotension is secondary to cardiac arrhythmia.
  • QRS Widening. Norpace CR may widen the QRS complex. If this happens, your doctor will stop Norpace CR. 
  • Q-T Prolongation. Norpace may cause prolongation of the QT interval. Your doctor will monitor you closely.
  • Low blood sugar. Norpace may lower blood sugar levels.
  • Heart block. If first degree block develops, your doctor will reduce your Norpace CR dose. 
  • Anticholinergic activity. Norpace should not be used in patients with glaucoma, myasthenia gravis, or urinary retention.

Do not take Norpace CR if you:

  • are allergic to Norpace CR or any of its ingredients
  • have cardiogenic shock
  • have a preexisting second- or third-degree AV block (if no pacemaker is present)
  • have congenital Q-T prolongation

Norpace CR Food Interactions

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Norpace CR, there are no specific foods that you must exclude from your diet when receiving this medication.

Inform MD

Before taking Norpace CR, tell your doctor about all of your medical conditions. Especially tell your doctor if you:

  • are allergic to disopyramide (Norpace CR) or any other drugs.
  • have or have ever had congestive heart disease, high blood pressure, diabetes, kidney or liver disease, glaucoma, myasthenia gravis, urinary retention, or benign prostatic hypertrophy.
  • are pregnant, plan to become pregnant, or are breast-feeding. 
  • are having surgery, including dental surgery
  • use cigarettes and caffeine-containing beverages. These products may increase the irritability of your heart and interfere with the action of Norpace CR.

Norpace CR can make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you. Alcohol can add to the drowsiness caused by this medication.

Talk to your doctor about the risks and benefits of taking Norpace CR if you are 65 years of age or older. Older adults should not usually take Norpace CR because it is not as safe or effective as other medications that can be used to treat the same condition.

Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.

Norpace CR and Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

Norpace CR falls into category C. In animal studies, pregnant animals were given this medication and had some babies born with problems. No well-controlled studies have been done in humans. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.

Norpace CR and Lactation

Tell your doctor if you are breastfeeding or plan to breastfeed.

Norpace CR has been detected in human breast milk. Because of the possibility for adverse reactions in nursing infants from Norpace CR, a choice should be made whether to stop nursing or to stop use of this medication. The importance of the drug to the mother should be considered.

Norpace CR Usage

Take Norpace CR exactly as prescribed.

Norpace CR comes in capsule form and is taken twice every day. 

Do not cut, crush, or chew extended-release capsules; swallow them whole.

If you forget a dose, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Norpace CR Dosage

The dosage of Norpace CR must be individualized for each patient on the basis of response and tolerance.

The usual adult dosage of Norpace CR is 400 to 800 mg per day given in divided doses.

The recommended dosage for most adults is 600 mg/day given in divided doses (300 mg every 12 hours).

For patients whose body weight is less than 110 pounds (50 kg), the recommended dosage is 400 mg/day given in divided doses (200 mg every 12 hours). 

Norpace CR Overdose

If you take too much Norpace CR, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

Other Requirements

  • Store Norpace CR at room temperature.
  • Keep this and all medicines out of the reach of children.

Norpace CR FDA Warning

Mortality

In the National Heart, Lung and Blood Institute's Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multi-center, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had had a myocardial infarction more than 6 days but less than 2 years previously, an excessive mortality or non-fatal cardiac arrest rate (7.7%) was seen in patients treated with encainide or flecainide compared with that seen in patients assigned to carefully matched placebo-treated groups (3.0%). The average duration of treatment with encainide or flecainide in this study was 10 months.

The applicability of the CAST results to other populations (e.g., those without recent myocardial infarction) is uncertain. Considering the known proarrhythmic properties of Norpace CR and the lack of evidence of improved survival for any antiarrhythmic drug in patients without life-threatening arrhythmias, the use of Norpace CR as well as other antiarrhythmic agents should be reserved for patients with life-threatening ventricular arrhythmias.